gsthr logo
Quick links to detailed datasheets for France at gsthr.org

Smoking in France

Smoking is regulated and allowed in France but there are some restrictions and regulations on tobacco. Under these regulations, the sale of cigarettes is permitted only in tobacco shops (le bureau de tabac) with a license. Purchasing cigarettes online and from vending machines is not permitted, while importing cigarettes for trade is allowed with an appropriate license. All forms of advertising of tobacco products including cigarettes are banned. Additionally, health warnings on cigarette packaging are required, the minimum legal age for purchasing them is 18 years, and there are legal restrictions on smoking in public places. Cigarettes are subject to a total taxation rate of 83.78%, and an excise tax rate of 12%. Despite these regulatory measures, in 2024, France had around 15.7 million current adult smokers, representing an adult current smoking prevalence of 28.3%. Among adult males, the current smoking prevalence was 31.5%, while among adult females it was 25.5% in 2024. Back in 2022, this prevalence was 29.2%. The adult daily smoking prevalence was 22.7% in 2023. Mortality data show that in 2021 tobacco smoking led to 54,940 deaths in the country, including 40,956 among males and 13,984 among females. Overall, smoking comprised 8.55% of all deaths in France in 2021, including 12.7% of male deaths and 4.37% of female deaths.

Read articles from France

November 13, 2026 by clearingtheair.eu

EU Commission declines to confirm December timetable for nicotine rules

The European Commission has declined to confirm whether its proposed revision of the Tobacco Products Directive will be published in December, amid reports of a possible delay until January 2027.

The uncertainty follows reported concerns over the proposal's impact assessment, while Health Commissioner Olivér Várhelyi continues to face criticism for suggesting that newer nicotine products carry the same risks as conventional tobacco.

The developments raise important questions about scientific accuracy and transparency in EU tobacco policy. Future regulation should recognise differences in product risk and consider the role of smoke-free alternatives in reducing smoking-related harm.

November 12, 2026 by clearingtheair.eu

French Senate blocks nicotine vape starter

A proposal to ban nicotine vape starter packs in France has been blocked on procedural grounds, preventing a new restriction on products used by adults seeking alternatives to cigarettes.

The amendment would have prohibited selling vaping devices together with nicotine-containing e-liquids, potentially making it less convenient for smokers to begin switching.

Although the proposal did not proceed, similar restrictions could still be introduced. The debate highlights the importance of preserving access to effective smoking cessation tools, particularly as Cochrane evidence shows that nicotine e-cigarettes can help more people quit smoking than traditional nicotine replacement therapies.

October 27, 2026 by consideratepouchers.org

Four times Sweden's tax: inside the EU's new plan for nicotine pouches

The EU's latest tobacco tax proposal could introduce a minimum excise duty on nicotine pouches more than four times Sweden's current rate by 2032.

Under the draft agreement, taxation would increase progressively from 2028, potentially affecting the affordability of smoke-free nicotine alternatives across Europe. Sweden has raised objections, arguing that taxation should reflect differences in product risk.

The proposal raises important questions for tobacco harm reduction. Higher taxes on lower-risk products could weaken financial incentives for smokers to switch, highlighting the need for a risk-proportionate approach to nicotine taxation.

October 14, 2026 by clearingtheair.eu

INVESTIGATION: Who’s behind the anti-nicotine propaganda?

Anti-nicotine campaigns rarely present themselves as propaganda; they present themselves as protection. That is why scrutiny matters. Funding networks, advocacy strategies and institutional alliances can shape which evidence is amplified, which voices are excluded and how safer nicotine products are framed to the public. A serious public health debate should be able to follow the influence behind the message, especially when the result may be fewer options for adults trying to leave cigarettes behind.

September 24, 2026 by gfn.tv

France Banned Nicotine Pouches! What Happens Next?

France has chosen to close the door on nicotine pouches, but the demand they answered will not vanish with the ban. Adult smokers and nicotine users may now be pushed towards cross-border purchases, informal supply or the one product still widely available: cigarettes. That is the weakness of treating smoke-free alternatives as threats instead of regulating them as part of a risk hierarchy. The real test comes next — whether the ban reduces harm, or simply moves it somewhere less visible.

September 18, 2026 by vejpkollen.se

Column: "After the election, I dare to be a little optimistic about smoke-free nicotine”

Cautious optimism on smoke-free nicotine is justified when the debate begins to recognise evidence, consumer behaviour and the difference between use and harm. Sweden’s experience has shown that lower-risk alternatives can contribute to falling smoking rates when they are accessible, acceptable and regulated. The challenge now is to turn that lesson into policy without losing sight of youth protection or product standards. Progress depends on treating smoke-free nicotine as part of the solution, not as a problem to be managed out of sight.

September 04, 2026 by substack.com

Part One: From Pesticide to NRT: A Regulatory History of Nicotine

Nicotine’s history is far more complex than the way it is usually discussed. The same substance has been framed as poison, dependence driver, medicine and harm reduction tool, depending on dose, delivery and context. That matters because public health debates often flatten nicotine into a single moral category. Better policy starts by separating the substance from the smoke, the risk from the rhetoric, and the product from the purpose it may serve.

August 28, 2026 by substack.com

JAMA Article on E-Cigarettes Makes Refreshingly Sound Recommendations to Clinicians

A JAMA article supporting clinician conversations about e-cigarettes should make the debate more precise. The evidence is strongest for adult smokers who use vaping as a route away from cigarettes, not for vague claims about nicotine use in general. That distinction matters because policy can either support full switching or bury it under uncertainty. Medical guidance should separate evidence from values clearly enough for smokers to understand their options.

July 27, 2026 by yahoo.com

Op-Ed: No air conditioning, but Brussels wants to ban Zyn

Heat is no longer an abstract climate issue when people are trying to sleep, work or stay safe in homes built for a cooler past. The air-conditioning debate shows how quickly adaptation becomes political: some see cooling as wasteful, others as basic protection against extreme heat. A serious response should not shame people for needing relief, but make cooling cleaner, more efficient and more accessible. Climate policy has to help people live with the risks already here, not only argue about the emissions still to come.

June 08, 2026 by rstreet.org

“Let Them Eat Cake”: Harm Reduction Edition

France's ban on oral nicotine products contradicts its successful harm reduction efforts against smoking, with adult smoking decreasing to 18.2% in 2024. Usage of reduced-risk products, like vapes and nicotine pouches, has aided in this progress. Nicotine pouches have shown to be safer than cigarettes, with minimal youth-related issues. Banning pouches while leaving more harmful tobacco legal misguides harm reduction principles. Enforcing prohibition could lead to an unregulated market. France should opt for regulation, implementing age restrictions and quality control measures. The ban overlooks evidence and may harm public health, disconnecting from successful smoking reduction strategies.